Wilmer Cutler Pickering Hale and Dorr advised Karyopharm Therapeutics Inc. on the transactions. Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies,...
Karyopharm’s Refinancing Transactions and Amended Royalty Agreement
Alethea’s $20 Million Series B Funding Round
Wilmer Cutler Pickering Hale and Dorr represented Alethea in the transaction. Alethea, a leading technology company in disinformation detection and mitigation, announced it has raised $20 million in Series...
SailPoint Technologies’ Acquisition of SecZetta
Wilmer Cutler Pickering Hale and Dorr advised SecZetta on the deal. SailPoint Technologies, Inc., a leader in enterprise identity security, announced that it acquired firm client...
MBX Biosciences’ $115 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on the deal while WilmerHale advised Wellington Management. MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision...
Material Bank’s $175 Million Series D Funding
WilmerHale advised General Catalyst, while Latham & Watkins represented Brookfield, the lead investor, in the financing round. Fenwick advised Material Bank. Material Bank, a digital marketplace...
ImmPACT Bio’s $111 Million Series B Financing
Wilmer Cutler Pickering Hale and Dorr advised ImmPACT Bio on the deal. ImmPACT Bio, a clinical-stage company developing transformative logic-gate based chimeric antigen receptor (CAR) T-cell...
Esme Learning Solutions’ $15 Million Series A Funding Round
Wilmer Cutler Pickering Hale and Dorr advised Esme Learning Solutions on the deal. Esme Learning Solutions, a global online learning platform, announced that is has raised...
Ameresco’s $140M Shares Public Offering
Wilmer Cutler Pickering Hale and Dorr advised Ameresco, Inc. on the deal. Ameresco, Inc., a leading clean technology integrator specializing in energy efficiency and renewable energy,...